Revolution MD Secures United States Patent for AI-Powered Controlled-Substance Oversight System
KNOXVILLE, Tenn., April 17, 2026 /PRNewswire/ — Revolution MD, a leader in safe, controlled delivery of high-risk medications like opioids and other controlled... Read more.
MediaPET.ai Introduces a New Way to Create Video: From Editing to Directing with AI
Version 2.1 replaces timeline-based editing with an AI collaborator that understands and executes across an entire video project—making it the easiest way to create... Read more.
Doba Launches Mother’s Day Initiative to Support Mom Entrepreneurs Building Online Businesses
SALT LAKE CITY, April 17, 2026 /PRNewswire/ — Doba, a leading dropshipping platform, today announced a Mother’s Day initiative aimed at supporting mom... Read more.
Red Wheel/Weiser Acquires Watkins Publishing, Uniting Two Historic Leaders in Mind, Body, Spirit Publishing
NEWBURYPORT, Mass. and LONDON, April 17, 2026 /PRNewswire/ — Red Wheel/Weiser announces the acquisition of the majority of the titles of Watkins Publishing,... Read more.
InflexionPoint Announces the Appointment of Pete Guzior as Chief Revenue Officer
Veteran manufacturing industry executive will lead the expansion of the company’s footprint and offerings, including AI and managed services RED BANK, N.J.,... Read more.
Nauticus Robotics Announces 1-for-8 Reverse Stock Split
HOUSTON, April 17, 2026 /PRNewswire/ — Nauticus Robotics, Inc. (NASDAQ: KITT, “Nauticus” or the “Company”) today announced that it... Read more.
iQIYI Deepens Its Presence at BIFF With AI Agent Nadou Pro and a New Film Screening
BEIJING, April 17, 2026 /PRNewswire/ — On April 16, iQIYI, China’s leading online entertainment platform, celebrated the opening of the 16th Beijing... Read more.
Scotiabank Comments on Expected Contribution from KeyCorp’s First Quarter Earnings
TORONTO, April 17, 2026 /CNW/ – Scotiabank announced today that the expected net income contribution from its ownership interest in KeyCorp will be approximately... Read more.
Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus TRODELVY® and Unveils Partnered Novel IPN01203/STAR0501 STAR Program in Phase 1 at AACR 2026
Encouraging Phase 2 clinical activity with confirmed complete responses observed in heavily pretreated metastatic breast cancer across both TNBC and HR+/HER2- subtypes... Read more.
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center
IRVING, Texas, April 17, 2026 /PRNewswire/ — Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision... Read more.